Nextgen Healthcare Inc (NASDAQ:NXGN) – Equities research analysts at Piper Jaffray Companies dropped their Q3 2019 EPS estimates for Nextgen Healthcare in a report issued on Wednesday, October 31st. Piper Jaffray Companies analyst S. Wieland now expects that the company will earn $0.10 per share for the quarter, down from their prior forecast of $0.14. Piper Jaffray Companies also issued estimates for Nextgen Healthcare’s Q4 2019 earnings at $0.10 EPS, FY2019 earnings at $0.56 EPS, Q1 2020 earnings at $0.15 EPS, Q2 2020 earnings at $0.24 EPS, Q3 2020 earnings at $0.19 EPS, Q4 2020 earnings at $0.18 EPS and FY2020 earnings at $0.73 EPS.
NXGN has been the topic of a number of other reports. KeyCorp dropped their price objective on Nextgen Healthcare from $17.00 to $16.00 and set an “underweight” rating on the stock in a research note on Wednesday, October 31st. Cantor Fitzgerald dropped their price target on Nextgen Healthcare from $26.00 to $23.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 31st. Morgan Stanley raised Nextgen Healthcare from an “underweight” rating to an “equal weight” rating and upped their price target for the stock from $12.00 to $16.00 in a research note on Thursday, November 1st. Finally, TheStreet raised Nextgen Healthcare from a “c” rating to a “b-” rating in a research note on Thursday, November 1st.
Shares of NASDAQ:NXGN opened at $15.26 on Monday. The stock has a market capitalization of $975.85 million, a PE ratio of 26.77, a price-to-earnings-growth ratio of 2.93 and a beta of 0.93. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.33 and a current ratio of 1.33. Nextgen Healthcare has a 1 year low of $12.24 and a 1 year high of $23.73.
Nextgen Healthcare (NASDAQ:NXGN) last announced its quarterly earnings data on Tuesday, October 30th. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.05. The company had revenue of $130.30 million for the quarter, compared to the consensus estimate of $134.55 million. Nextgen Healthcare had a return on equity of 10.23% and a net margin of 1.17%. The firm’s revenue was down 1.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.22 EPS.
Hedge funds have recently bought and sold shares of the stock. Bank of Montreal Can acquired a new position in Nextgen Healthcare during the 3rd quarter worth approximately $165,000. Hanson & Doremus Investment Management acquired a new position in Nextgen Healthcare during the 3rd quarter worth approximately $208,000. Public Employees Retirement Association of Colorado acquired a new position in Nextgen Healthcare during the 3rd quarter worth approximately $239,000. NJ State Employees Deferred Compensation Plan acquired a new position in Nextgen Healthcare during the 3rd quarter worth approximately $402,000. Finally, Louisiana State Employees Retirement System acquired a new position in Nextgen Healthcare during the 3rd quarter worth approximately $420,000. 69.03% of the stock is currently owned by institutional investors and hedge funds.
Nextgen Healthcare Company Profile
NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
Recommended Story: Trading Strategy
Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.